Banking Stem Cells
نویسنده
چکیده
The Journal of Clinical Pediatric Dentistry Volume 33, Number 4/2009 289 INTRODUCTION Tooth banking is based on the firm belief that personalized medicine is the most promising avenue for treating challenging diseases and injuries that could occur throughout lifetime. Stem cell therapy has been used around the world to treat such conditions, and the full promise of stem cell therapy has only been glimpsed so far. There is an abundant source of adult Stem cells in the Human Exfoliated Deciduous teeth (SHED). Recent studies have shown that SHED have the ability to develop into more types of body tissues than other types of stem cells. Researchers have found the pulp of exfoliated deciduous teeth to contain chondrocytes, osteoblasts, adipocytes, and mesenchymal stem cells. All of these cell types hold enormous potential for the therapeutic treatment of: Neuronal degenerative disorders such as Alzheimer’s, Parkinson’s, and ALS (Amyotrophic Lateral Sclerosis or Lou Gehrig’s Disease); chronic heart conditions such as congestive heart failure and chronic ischemic heart disease; periodontal disease and to grow replacement teeth and bone. One of the most important potential applications using these cells is for the treatment of paralysis due to spinal cord injury which has already been done using mesenchymal stem cells from other sources. The application of stem cell therapy using SHED to treat these diseases is currently being pursued by many researchers at the institutions around the world. There is much research left to be conducted, but the existing research has clearly shown that primary teeth are a better source for therapeutic stem cells than wisdom teeth, and orthodontically extracted teeth. Keeping this premise in mind, the concept of tooth banking has popularized and various companies have set up tooth banks to tap the potential of this new and innovative approach for preserving SHED and stem cells from other dental sources. This review will focus on the potential applications of SHED as well as the techniques adopted for their preservation.
منابع مشابه
A Review of Procedures Involved in Human Umbilical Cord Blood Banking and Transplantation
Cord blood hematopoietic stem cells are widely used as an alternative source for hematopoietic stem cells transplant. Increasing rate of patients who need hematopoietic stem cells transplant and many advantages of cord blood in comparison to bone marrow hematopoietic stem cells, have promoted banking of cord blood units. Cord blood banking requires accurate steps in donor selection, cord blood ...
متن کاملMild hypoxia and human bone marrow mesenchymal stem cells synergistically enhance expansion and homing capacity of human cord blood CD34+ stem cells
Objective(s): Cord blood (CB) is known as a valuable source of hematopoietic stem cells (HSC). Identifying strategies that enhance expansion and maintain engraftment and homing capacity of HSCs can improve transplant efficiency. In this study, we examined different culture conditions on ex vivo expansion and homing capacity of CB-HSCs. Materials and Methods: In this study, 4-5 different units o...
متن کاملInm-9: Global Approach toward Banking Cord Blood Stem Cells
Umbilical cord blood is the baby's blood left over in the umbilical cord and placenta after a baby is delivered and the cord is cut. Cord blood has all of the features of regular blood, but it is also a rich source of hematopoietic stem cells. Hematopoietic stem cells are unspecialized cells that produce all blood cells. These include: • Platelets, which are needed for blood clotting • Red...
متن کاملInm-7: Cord Blood Banking Potential and Prospective
The term “cord blood” is used for blood that is drawn from the umbilical cord and the placenta after a baby is born. Up until recently this afterbirth was discarded as medical waste. Cord blood contains stem cells that may be frozen for later use in medical therapies, such as stem cell transplantation or regenerative medicine. The umbilical cord and placenta are rich sources of stem cells. Thes...
متن کاملIn vitro Induction of Fetal Hemoglobin in Erythroid Cells Derived from CD133 Cells by Transforming Growth Factor-b and Stem Cell Factor
Increased fetal hemoglobin (HbF) in b-globin gene disorders ameliorates the clinical symptoms of the underlying disease. 5-azacytidine, butyrate and hydroxyurea, have been shown to activate g-globin gene expression. It has also been found that hematopoietic growth factors can influence expression of g-globin in erythroid cultures and in animal models. This study was designed to evaluate the in ...
متن کاملOnm-19: The Role of Cord Blood Preservationin Cell Therapy
s:3604:"During pregnancy, the placenta delivers "cord blood" to the baby through the umbilical cord serving as a lifeline of nourishment from the mother to baby. At birth, "cord blood" remains in the umbilical cord and placenta and until recently, had typically been discarded. The tragedy of this practice is that "cord blood" contains very special cells called "stem cells". Recent advances in m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2009